Desmoid Tumor Research Foundation

Make It Possible!

Join our year-end campaign to help achieve our 2019 research priorities

Join Today

#soliloquy-container-16235{opacity:1}#soliloquy-container-16235 li > .soliloquy-caption{display:none}#soliloquy-container-16235 li:first-child > .soliloquy-caption{display:block} Hero-Image_MakeItPossible_rocke

For the latest DTRF news sign up for one of our newsletters to stay informed.

FOR PATIENTS

FOR PHYSICIANS

FDA Approves Fast Track Designation for Nirogacestat

2019 Western Regional Patient Meeting

2018 DTRF Patient Meeting Presentations

Int’l DTRF Desmoid Tumor Research Workshop

Interim Results from Phase III Sorafenib Trial

Upcoming Clinical Trials for Tegavivint and Nirogacestat

DFC- Desmoid Tumour Foundation of Canada

Announcements

FDA Approves Fast Track Designation for Nirogacestat

Sorafenib Extends PFS in Desmoid TumorsNIH-funded study shows sorafenib improves progression-free survival for patient

Tegavivint Trial LaunchesIterion Therapeutics, formerly known as Beta Cat Pharmaceuticals, today announced that it has initiated a multi-center Phase I clinical study of Tegavivint

Abstract for Phase II Pazopanib TrialDT are a group of locally aggressive tumors of fibroblastic origin that can lead

ASCO Presentation for Phase II Pazopanib TrialPazopanib versus IV methotrexate/vinblastine in
adult patients

DTRF’s 2018 Grant AwardsGerlinde Wernig, MD, Assistant Professor of Pathology, Standford Univesity School

Upcoming Clinical TrialsVisit our clinical trials page to find information on all desmoid tumor clinical trials.

2018 DTRF Patient Meeting Presentations

Int’l DTRF Desmoid Tumor Research WorkshopSave the date for the Fifth Annual DTRF International Desmoid Tumor Research Workshop

Desmoid Tumour Foundation of CanadaThey donated $85,000 to DTRF research initiatives in 2018!

Click here for archive of UPDATES

DTRF will hold our Second Western Regional Patient Meeting on Saturday, April 13th in South San Francisco, CA. This meeting is jointly sponsored by DTRF and Stanford Sarcoma Program. Experts will discuss the latest treatment options and you’ll learn firsthand what DTRF is doing to advocate for desmoid tumor research. More details »

On Saturday, September 22nd, in Philadelphia, PA, DTRF held its Annual Patient Meeting. This event educates and empowers patients and caregivers by teaching them about the latest research & treatment options available. Learn more »

DTRF encourages you to join the DTRF Patient Registry in order to facilitate research efforts. With access to your experience as a patient, researchers will be able to continue learning and making new discoveries in the field of desmoid tumors. If you have ever had a desmoid tumor, you can participate. Learn more »

If you have an upcoming desmoid tumor surgery, you can potentially contribute to furthering research on the disease. The DTRF is partnering with Pattern.org to send tissue samples to the Broad Institute of MIT and Harvard (www.broadinstitute.org) for inclusion in their Cancer Cell Line Project. Learn more »

Because desmoid tumors are so rare, they are often misunderstood. Review commonly asked questions about classification, pregnancy, recurrence and mutation types. This is a great resource for newly-diagnosed patients.